Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature

Psychiatric Quarterly

Volumn 87, Issue 3, 2016, Pages 559-569

  Sahu, Geetanjali ^a   Malavade, Kishor ^a   Jacob, Theresa ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

BDNF; BDNFval66met polymorphism; Childhood trauma; Cognition in schizophrenia; Endophenotype; Genetics

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

AMYGDALA; ARTICLE; BRAIN REGION; BRAIN SIZE; CHILD; CHILDHOOD INJURY; COGNITIVE DEFECT; EMOTION; GENE CONTROL; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HIPPOCAMPUS; HUMAN; SCHIZOPHRENIA; CHILDHOOD TRAUMA SURVIVOR; ENDOPHENOTYPE; GENETICS; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT SURVIVORS OF CHILD ADVERSE EVENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITIVE DYSFUNCTION; ENDOPHENOTYPES; GENE-ENVIRONMENT INTERACTION; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84948174863     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-015-9409-8     Document Type: Article

References (49)

1. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? The American Journal of Psychiatry 153(3):321–330, 1996.
2. Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff? Schizophrenia Bulletin 26:119–136, 2000.
3. Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophrenia Research 72:41–51, 2004.
4. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK: Identification of separable cognitive factors in schizophrenia. Schizophrenia Research 72:29–39, 2004.
5. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry 64(6):633–647, 2007a.
6. Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA: Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison. The American Journal of Psychiatry 164(7):1061–1071, 2007b.
7. Carrion RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA: Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. American Journal of Psychiatry 168(8):806–813, 2011.
8. Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH: Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin 38(4):865–872, 2012.
9. Bayer TA, Falkai P, Maier W: Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the “two hit hypothesis”. Journal of Psychiatric Research 33(6):543–548, 1999.
10. Caspi A, Moffitt TE: Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nature Reviews Neuroscience 7(7):583–590, 2006.
11. Braff DL, Freedman R, Schork NJ, Gottesman II: Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 33(1):21–32, 2007.
12. Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK: Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. The Journal of Nervous and Mental Disease 194(4):255–260, 2006.
13. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS: The consortium on the genetics of schizophrenia: Neurocognitive endophenotypes. Schizophrenia Bulletin 33(1):49–68, 2007.
14. Burdick KE, Ketter TA, Goldberg JF, Calabrese JR: Assessing cognitive function in bipolar disorder: Challenges and recommendations for clinical trial design. The Journal of Clinical Psychiatry 76(3):e342–e350, 2015.
15. Phelps EA: Emotion and cognition: Insights from studies of the human amygdala. Annual Review of Psychology 57:27–53, 2006.
16. Gorman JM, Kent JM, Sullivan GM, Coplan JD: Neuroanatomical hypothesis of panic disorder, revised. The American Journal of Psychiatry 157(4):493–505, 2000.
17. Desmedt A, Marighetto A, Richter-Levin G, Calandreau L: Adaptive emotional memory: The key hippocampal-amygdalar interaction. Stress 11:1–12, 2015.
18. Selemon LD, Zecevic N: Schizophrenia: A tale of two critical periods for prefrontal cortical development. Translational Psychiatry 5:e623, 2015.
19. Hornig T, Valerius T, Feige B, Bubl E, Olbrich HM, Van-Elst LT: Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: Negative symptomatology is associated with specific mnestic deficits in schizophrenic patients. BMC Psychiatry 14:326, 2014.
20. Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, Nakazato M, Shimizu E, Hashimoto K, Iyo M: A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. Psychiatry Research 215(2):268–273, 2014.
21. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters 401(1–2):1–5, 2006.
22. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37(12):1553–1561, 1998.
23. Fernandes BS, Berk M, Turck CW, Steiner J, Gonçalves CA: Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: A comparative meta-analysis. Molecular Psychiatry 19(7):750–751, 2014.
24. Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, Wittfeld K, Grabe HJ, Lang UE, Fusar-Poli P, Borgwardt S: BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 55:107–118, 2015.
25. Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC: A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. The Journal of Physiology 586(Pt 23):5717–5725, 2008.
26. Tamminga CA, Stan AD, Wagner AD: The hippocampal formation in schizophrenia. American Journal of Psychiatry 167(10):1178–1193, 2010.
27. Boyer P, Phillips JL, Rousseau FL, Ilivitsky S: Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia. Brain Research Reviews 54(1):92–112, 2007.
28. Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S: Hippocampal interneurons are abnormal in schizophrenia. Schizophrenia Research 131(1–3):165–73, 2011.
29. Shenton ME, Gerig G, McCarley RW, Szekely G, Kikinis R: Amygdala hippocampal shape differences in schizophrenia: The application of 3D shape models to volumetric MR data. Psychiatry Research 115(1–2):15–35, 2002.
30. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ: Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A metaanalytic study. Archives of General Psychiatry 55(5):433–440, 1998.
31. Adriano F, Caltagirone C, Spalletta G: Hippocampal volume reduction in first-episode and chronic schizophrenia: A review and meta-analysis. The Neuroscientist 18(2):180–200, 2012.
32. Schäfer I, Fisher HL: Childhood trauma and psychosis—What is the evidence? Dialogues in Clinical Neuroscience 13(3):360–365, 2011.
33. Várese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, Read J, van Os J, Bentall RP: Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective and cross-sectional cohort studies. Schizophrenia Bulletin 38(4):661–671, 2012.
34. Trotta A, Di Forti M, Mondelli V, Dazzan P, Pariante C, David A, Mulè A, Ferraro L, Formica I, Murray RM, Fisher HL: Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls. Schizophrenia Research 150(1):169–175, 2013.
35. van Winkel R, van Nierop M, Myin-Germeys I, van Os J: Childhood trauma as a cause of psychosis: Linking genes, psychology, and biology. Canadian Journal of Psychiatry 58(1):44–51, 2013.
36. Aas M, Navari S, Gibbs A, Mondelli V, Fisher HL, Morgan C, Morgan K, MacCabe J, Reichenberg A, Zanelli J, Fearon P, Jones PB, Murray RM, Pariante CM, Dazzan P: Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis? Schizophrenia Research 137(1–3):73–79, 2012.
37. Aas M, Djurovic S, Athanasiu L, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, Melle I: Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders. Schizophrenia Bulletin 38(1):15–22, 2012.
38. Mondelli V, Cattaneo A, Murri MB, Di Forti M, Handley R, Hepgul N, Miorelli A, Navari S, Papadopoulos AS, Aitchison KJ, Morgan C, Murray RM, Dazzan P, Pariante CM: Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume. The Journal of Clinical Psychiatry 72(12):1677–1684, 2011.
39. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM: Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Molecular Psychiatry 14(7):681–695, 2009.
40. Dalvie S, Stein DJ, Koenen K, Cardenas V, Cuzen NL, Ramesar R, Fein G, Brooks SJ: The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry 14:328, 2014.
41. Aas M, Haukvik UK, Djurovic S, Tesli M, Athanasiu L, Bjella T, Hansson L, Cattaneo A, Agartz I, Andreassen OA, Melle I: Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. Journal of Psychiatric Research 59:14–21, 2014.
42. Aas M, Haukvik UK, Djurovic S, Bergmann O, Athanasiu L, Tesli MS, Hellvin T, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, and Melle I: BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 46:181–188, 2013.
43. Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, Russo M, Reichenberg A, Falcone MA, Mondelli V, O’Connor J, David A, McGuire P, Pariante C, Di Forti M, Murray RM, Bonaccorso S: Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis. Schizophrenia Research 159(1):56–61, 2014.
44. Bortoluzzi A, Salum GA, Blaya C, Silveira PP, Grassi-Oliveira R, da Rosa ED, de Aguiar BW, Stertz L, Bosa VL, Schuch I, Goldani M, Kapczinski F, Leistner-Segal S, Manfro GG: Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF. Journal of Psychiatric Research 59:8–13, 2014.
45. Hernaus D, van Winkel R, Gronenschild E, Habets P, Kenis G, Marcelis M, van Os J, Myin-Germeys I, Collip D: Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performance. PLoS One 9(3):e92722, 2014.
46. Vrijsen JN, van Oostrom I, Arias-Vásquez A, Franke B, Becker ES, Speckens A: Association between genes, stressful childhood events and processing bias in depression vulnerable individuals. Genes, Brain and Behavior 13(5):508–516, 2014.
47. Savitz J, van der Merwe L, Stein DJ, Solms M, Ramesar R: Genotype and childhood sexual trauma moderate neurocognitive performance: A possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biological Psychiatry 62(5):391–399, 2007.
48. Roth TL, Lubin FD, Funk AJ, Sweatt JD: Lasting epigenetic influence of early-life adversity on the BDNF gene. Biological Psychiatry 65(9):760–769, 2009.
49. Alemany S, Arias B, Aguilera M, Villa H, Moya J, Ibáñez MI, Vossen H, Gastó C, Ortet G, Fañanás L: Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. The British Journal of Psychiatry 199(1):38–42, 2011.